nodes	percent_of_prediction	percent_of_DWPC	metapath
Sofosbuvir—ABCB1—hematologic cancer	0.297	1	CbGaD
Sofosbuvir—ABCB1—Lenalidomide—hematologic cancer	0.0644	0.141	CbGbCtD
Sofosbuvir—ABCB1—Daunorubicin—hematologic cancer	0.0378	0.0826	CbGbCtD
Sofosbuvir—ABCB1—Alitretinoin—hematologic cancer	0.037	0.0809	CbGbCtD
Sofosbuvir—ABCB1—Imatinib—hematologic cancer	0.0289	0.0633	CbGbCtD
Sofosbuvir—ABCB1—Nilotinib—hematologic cancer	0.0263	0.0575	CbGbCtD
Sofosbuvir—ABCB1—Vinorelbine—hematologic cancer	0.0261	0.057	CbGbCtD
Sofosbuvir—ABCB1—Dasatinib—hematologic cancer	0.0232	0.0508	CbGbCtD
Sofosbuvir—ABCB1—Mitoxantrone—hematologic cancer	0.0229	0.0502	CbGbCtD
Sofosbuvir—ABCB1—Betamethasone—hematologic cancer	0.0205	0.0448	CbGbCtD
Sofosbuvir—ABCB1—Gemcitabine—hematologic cancer	0.0203	0.0444	CbGbCtD
Sofosbuvir—ABCB1—Prednisolone—hematologic cancer	0.0202	0.0442	CbGbCtD
Sofosbuvir—ABCB1—Prednisone—hematologic cancer	0.0191	0.0417	CbGbCtD
Sofosbuvir—ABCB1—Irinotecan—hematologic cancer	0.0181	0.0395	CbGbCtD
Sofosbuvir—ABCB1—Vinblastine—hematologic cancer	0.0161	0.0351	CbGbCtD
Sofosbuvir—ABCB1—Vincristine—hematologic cancer	0.0158	0.0346	CbGbCtD
Sofosbuvir—ABCB1—Cisplatin—hematologic cancer	0.0147	0.0322	CbGbCtD
Sofosbuvir—ABCB1—Etoposide—hematologic cancer	0.0145	0.0317	CbGbCtD
Sofosbuvir—ABCB1—Dexamethasone—hematologic cancer	0.0119	0.026	CbGbCtD
Sofosbuvir—ABCB1—Doxorubicin—hematologic cancer	0.00987	0.0216	CbGbCtD
Sofosbuvir—ABCB1—Methotrexate—hematologic cancer	0.00956	0.0209	CbGbCtD
Sofosbuvir—ABCB1—Abacavir transmembrane transport—SLC22A1—hematologic cancer	0.000808	0.0621	CbGpPWpGaD
Sofosbuvir—ABCB1—Abacavir transmembrane transport—ABCG2—hematologic cancer	0.00072	0.0553	CbGpPWpGaD
Sofosbuvir—ABCB1—Codeine and Morphine Metabolism—ABCC3—hematologic cancer	0.000606	0.0466	CbGpPWpGaD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PIM2—hematologic cancer	0.000596	0.0458	CbGpPWpGaD
Sofosbuvir—ABCB1—Codeine and Morphine Metabolism—UGT1A1—hematologic cancer	0.00057	0.0438	CbGpPWpGaD
Sofosbuvir—ABCB1—Abacavir transport and metabolism—SLC22A1—hematologic cancer	0.000464	0.0356	CbGpPWpGaD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—LYL1—hematologic cancer	0.000452	0.0347	CbGpPWpGaD
Sofosbuvir—ABCB1—Abacavir transport and metabolism—ABCG2—hematologic cancer	0.000414	0.0318	CbGpPWpGaD
Sofosbuvir—ABCB1—Drug Induction of Bile Acid Pathway—ABCC3—hematologic cancer	0.000332	0.0255	CbGpPWpGaD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—NSD1—hematologic cancer	0.000291	0.0224	CbGpPWpGaD
Sofosbuvir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	0.000241	0.0185	CbGpPWpGaD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCR—hematologic cancer	0.000237	0.0182	CbGpPWpGaD
Sofosbuvir—ABCB1—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	0.0002	0.0154	CbGpPWpGaD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—BNIP3—hematologic cancer	0.000195	0.015	CbGpPWpGaD
Sofosbuvir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	0.000191	0.0146	CbGpPWpGaD
Sofosbuvir—ABCB1—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	0.000188	0.0145	CbGpPWpGaD
Sofosbuvir—ABCB1—ABC-family proteins mediated transport—ABCC3—hematologic cancer	0.000182	0.014	CbGpPWpGaD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—GATA2—hematologic cancer	0.00018	0.0138	CbGpPWpGaD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—hematologic cancer	0.000167	0.0129	CbGpPWpGaD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—ID2—hematologic cancer	0.000155	0.0119	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—PPP1R13L—hematologic cancer	0.000152	0.0117	CbGpPWpGaD
Sofosbuvir—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	0.000147	0.0113	CbGpPWpGaD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—MCL1—hematologic cancer	0.000132	0.0101	CbGpPWpGaD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—hematologic cancer	0.000129	0.00991	CbGpPWpGaD
Sofosbuvir—ABCB1—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.000121	0.00931	CbGpPWpGaD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—CA9—hematologic cancer	0.000121	0.00926	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—CXCR5—hematologic cancer	0.000118	0.00908	CbGpPWpGaD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—hematologic cancer	0.000116	0.00891	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—CXCL13—hematologic cancer	0.000104	0.00802	CbGpPWpGaD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—NPM1—hematologic cancer	0.000103	0.00795	CbGpPWpGaD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—hematologic cancer	9.95e-05	0.00764	CbGpPWpGaD
Sofosbuvir—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	9.63e-05	0.0074	CbGpPWpGaD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—hematologic cancer	9.61e-05	0.00738	CbGpPWpGaD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—ABCG2—hematologic cancer	9.14e-05	0.00702	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—FOXP3—hematologic cancer	8.96e-05	0.00688	CbGpPWpGaD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—TFRC—hematologic cancer	8.15e-05	0.00626	CbGpPWpGaD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—EPO—hematologic cancer	7.84e-05	0.00602	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—IL13—hematologic cancer	7.66e-05	0.00589	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—GZMB—hematologic cancer	7.66e-05	0.00589	CbGpPWpGaD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—hematologic cancer	7.47e-05	0.00574	CbGpPWpGaD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—CXCR4—hematologic cancer	7.31e-05	0.00561	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—CASP7—hematologic cancer	7.02e-05	0.00539	CbGpPWpGaD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—hematologic cancer	6.83e-05	0.00525	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—hematologic cancer	6.8e-05	0.00522	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—PRKCZ—hematologic cancer	6.79e-05	0.00522	CbGpPWpGaD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—hematologic cancer	6.73e-05	0.00517	CbGpPWpGaD
Sofosbuvir—Infection—Betamethasone—hematologic cancer	6.47e-05	0.000278	CcSEcCtD
Sofosbuvir—Dizziness—Vincristine—hematologic cancer	6.46e-05	0.000278	CcSEcCtD
Sofosbuvir—Rash—Carmustine—hematologic cancer	6.45e-05	0.000277	CcSEcCtD
Sofosbuvir—Dermatitis—Carmustine—hematologic cancer	6.44e-05	0.000277	CcSEcCtD
Sofosbuvir—Vomiting—Alitretinoin—hematologic cancer	6.44e-05	0.000277	CcSEcCtD
Sofosbuvir—Infestation—Doxorubicin—hematologic cancer	6.43e-05	0.000276	CcSEcCtD
Sofosbuvir—Infestation NOS—Doxorubicin—hematologic cancer	6.43e-05	0.000276	CcSEcCtD
Sofosbuvir—Anaemia—Prednisone—hematologic cancer	6.42e-05	0.000276	CcSEcCtD
Sofosbuvir—Headache—Carmustine—hematologic cancer	6.41e-05	0.000275	CcSEcCtD
Sofosbuvir—Dyspnoea—Triamcinolone—hematologic cancer	6.4e-05	0.000275	CcSEcCtD
Sofosbuvir—Rash—Alitretinoin—hematologic cancer	6.39e-05	0.000275	CcSEcCtD
Sofosbuvir—Nervous system disorder—Dexamethasone—hematologic cancer	6.39e-05	0.000274	CcSEcCtD
Sofosbuvir—Nervous system disorder—Betamethasone—hematologic cancer	6.39e-05	0.000274	CcSEcCtD
Sofosbuvir—Agitation—Prednisone—hematologic cancer	6.38e-05	0.000274	CcSEcCtD
Sofosbuvir—Dermatitis—Alitretinoin—hematologic cancer	6.38e-05	0.000274	CcSEcCtD
Sofosbuvir—Vomiting—Ifosfamide—hematologic cancer	6.37e-05	0.000274	CcSEcCtD
Sofosbuvir—Headache—Alitretinoin—hematologic cancer	6.35e-05	0.000273	CcSEcCtD
Sofosbuvir—Diarrhoea—Gemcitabine—hematologic cancer	6.34e-05	0.000272	CcSEcCtD
Sofosbuvir—Nausea—Thalidomide—hematologic cancer	6.33e-05	0.000272	CcSEcCtD
Sofosbuvir—Dyspepsia—Triamcinolone—hematologic cancer	6.32e-05	0.000271	CcSEcCtD
Sofosbuvir—Rash—Ifosfamide—hematologic cancer	6.32e-05	0.000271	CcSEcCtD
Sofosbuvir—Dermatitis—Ifosfamide—hematologic cancer	6.31e-05	0.000271	CcSEcCtD
Sofosbuvir—Dizziness—Irinotecan—hematologic cancer	6.29e-05	0.00027	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—CD40—hematologic cancer	6.26e-05	0.00481	CbGpPWpGaD
Sofosbuvir—Body temperature increased—Etoposide—hematologic cancer	6.25e-05	0.000269	CcSEcCtD
Sofosbuvir—Eye disorder—Methotrexate—hematologic cancer	6.23e-05	0.000268	CcSEcCtD
Sofosbuvir—Vomiting—Vincristine—hematologic cancer	6.21e-05	0.000267	CcSEcCtD
Sofosbuvir—Asthenia—Cisplatin—hematologic cancer	6.2e-05	0.000266	CcSEcCtD
Sofosbuvir—Fatigue—Triamcinolone—hematologic cancer	6.19e-05	0.000266	CcSEcCtD
Sofosbuvir—Rash—Vincristine—hematologic cancer	6.16e-05	0.000265	CcSEcCtD
Sofosbuvir—Dermatitis—Vincristine—hematologic cancer	6.15e-05	0.000264	CcSEcCtD
Sofosbuvir—Pain—Triamcinolone—hematologic cancer	6.14e-05	0.000264	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Epirubicin—hematologic cancer	6.13e-05	0.000264	CcSEcCtD
Sofosbuvir—Headache—Vincristine—hematologic cancer	6.12e-05	0.000263	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Doxorubicin—hematologic cancer	6.08e-05	0.000261	CcSEcCtD
Sofosbuvir—Nausea—Carmustine—hematologic cancer	6.08e-05	0.000261	CcSEcCtD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—hematologic cancer	6.06e-05	0.00466	CbGpPWpGaD
Sofosbuvir—Vomiting—Mitoxantrone—hematologic cancer	6.05e-05	0.00026	CcSEcCtD
Sofosbuvir—Vomiting—Irinotecan—hematologic cancer	6.05e-05	0.00026	CcSEcCtD
Sofosbuvir—Nausea—Alitretinoin—hematologic cancer	6.02e-05	0.000259	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Methotrexate—hematologic cancer	6.01e-05	0.000258	CcSEcCtD
Sofosbuvir—Rash—Mitoxantrone—hematologic cancer	6e-05	0.000258	CcSEcCtD
Sofosbuvir—Rash—Irinotecan—hematologic cancer	6e-05	0.000258	CcSEcCtD
Sofosbuvir—Dermatitis—Irinotecan—hematologic cancer	5.99e-05	0.000257	CcSEcCtD
Sofosbuvir—Dermatitis—Mitoxantrone—hematologic cancer	5.99e-05	0.000257	CcSEcCtD
Sofosbuvir—Chills—Methotrexate—hematologic cancer	5.98e-05	0.000257	CcSEcCtD
Sofosbuvir—Headache—Mitoxantrone—hematologic cancer	5.96e-05	0.000256	CcSEcCtD
Sofosbuvir—Headache—Irinotecan—hematologic cancer	5.96e-05	0.000256	CcSEcCtD
Sofosbuvir—Nausea—Ifosfamide—hematologic cancer	5.95e-05	0.000256	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5.93e-05	0.000255	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.93e-05	0.000255	CcSEcCtD
Sofosbuvir—Myalgia—Prednisone—hematologic cancer	5.92e-05	0.000254	CcSEcCtD
Sofosbuvir—Arthralgia—Prednisone—hematologic cancer	5.92e-05	0.000254	CcSEcCtD
Sofosbuvir—Diarrhoea—Cisplatin—hematologic cancer	5.91e-05	0.000254	CcSEcCtD
Sofosbuvir—Anxiety—Prednisone—hematologic cancer	5.89e-05	0.000253	CcSEcCtD
Sofosbuvir—Alopecia—Methotrexate—hematologic cancer	5.89e-05	0.000253	CcSEcCtD
Sofosbuvir—Vomiting—Gemcitabine—hematologic cancer	5.89e-05	0.000253	CcSEcCtD
Sofosbuvir—Insomnia—Betamethasone—hematologic cancer	5.89e-05	0.000253	CcSEcCtD
Sofosbuvir—Insomnia—Dexamethasone—hematologic cancer	5.89e-05	0.000253	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	5.87e-05	0.000252	CcSEcCtD
Sofosbuvir—Rash—Gemcitabine—hematologic cancer	5.84e-05	0.000251	CcSEcCtD
Sofosbuvir—Dermatitis—Gemcitabine—hematologic cancer	5.84e-05	0.000251	CcSEcCtD
Sofosbuvir—Eye disorder—Epirubicin—hematologic cancer	5.83e-05	0.000251	CcSEcCtD
Sofosbuvir—Malnutrition—Methotrexate—hematologic cancer	5.81e-05	0.000249	CcSEcCtD
Sofosbuvir—Headache—Gemcitabine—hematologic cancer	5.8e-05	0.000249	CcSEcCtD
Sofosbuvir—Nausea—Vincristine—hematologic cancer	5.8e-05	0.000249	CcSEcCtD
Sofosbuvir—Dyspepsia—Dexamethasone—hematologic cancer	5.73e-05	0.000246	CcSEcCtD
Sofosbuvir—Dyspepsia—Betamethasone—hematologic cancer	5.73e-05	0.000246	CcSEcCtD
Sofosbuvir—Asthenia—Etoposide—hematologic cancer	5.68e-05	0.000244	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Doxorubicin—hematologic cancer	5.68e-05	0.000244	CcSEcCtD
Sofosbuvir—Body temperature increased—Triamcinolone—hematologic cancer	5.67e-05	0.000244	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—STAT1—hematologic cancer	5.67e-05	0.00436	CbGpPWpGaD
Sofosbuvir—Decreased appetite—Dexamethasone—hematologic cancer	5.66e-05	0.000243	CcSEcCtD
Sofosbuvir—Decreased appetite—Betamethasone—hematologic cancer	5.66e-05	0.000243	CcSEcCtD
Sofosbuvir—Nausea—Mitoxantrone—hematologic cancer	5.65e-05	0.000243	CcSEcCtD
Sofosbuvir—Nausea—Irinotecan—hematologic cancer	5.65e-05	0.000243	CcSEcCtD
Sofosbuvir—Infection—Prednisone—hematologic cancer	5.63e-05	0.000242	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Epirubicin—hematologic cancer	5.63e-05	0.000242	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.62e-05	0.000242	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.62e-05	0.000242	CcSEcCtD
Sofosbuvir—Back pain—Methotrexate—hematologic cancer	5.62e-05	0.000241	CcSEcCtD
Sofosbuvir—Fatigue—Betamethasone—hematologic cancer	5.61e-05	0.000241	CcSEcCtD
Sofosbuvir—Fatigue—Dexamethasone—hematologic cancer	5.61e-05	0.000241	CcSEcCtD
Sofosbuvir—Chills—Epirubicin—hematologic cancer	5.6e-05	0.000241	CcSEcCtD
Sofosbuvir—Pruritus—Etoposide—hematologic cancer	5.6e-05	0.000241	CcSEcCtD
Sofosbuvir—Pain—Betamethasone—hematologic cancer	5.57e-05	0.000239	CcSEcCtD
Sofosbuvir—Pain—Dexamethasone—hematologic cancer	5.57e-05	0.000239	CcSEcCtD
Sofosbuvir—Nervous system disorder—Prednisone—hematologic cancer	5.56e-05	0.000239	CcSEcCtD
Sofosbuvir—Alopecia—Epirubicin—hematologic cancer	5.52e-05	0.000237	CcSEcCtD
Sofosbuvir—Skin disorder—Prednisone—hematologic cancer	5.51e-05	0.000237	CcSEcCtD
Sofosbuvir—Nausea—Gemcitabine—hematologic cancer	5.5e-05	0.000236	CcSEcCtD
Sofosbuvir—Vomiting—Cisplatin—hematologic cancer	5.49e-05	0.000236	CcSEcCtD
Sofosbuvir—Vision blurred—Methotrexate—hematologic cancer	5.47e-05	0.000235	CcSEcCtD
Sofosbuvir—Rash—Cisplatin—hematologic cancer	5.45e-05	0.000234	CcSEcCtD
Sofosbuvir—Dermatitis—Cisplatin—hematologic cancer	5.44e-05	0.000234	CcSEcCtD
Sofosbuvir—Malnutrition—Epirubicin—hematologic cancer	5.43e-05	0.000233	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—HLA-DQA1—hematologic cancer	5.43e-05	0.00417	CbGpPWpGaD
Sofosbuvir—Diarrhoea—Etoposide—hematologic cancer	5.41e-05	0.000233	CcSEcCtD
Sofosbuvir—Eye disorder—Doxorubicin—hematologic cancer	5.4e-05	0.000232	CcSEcCtD
Sofosbuvir—Anaemia—Methotrexate—hematologic cancer	5.37e-05	0.000231	CcSEcCtD
Sofosbuvir—Back pain—Epirubicin—hematologic cancer	5.26e-05	0.000226	CcSEcCtD
Sofosbuvir—Dizziness—Etoposide—hematologic cancer	5.23e-05	0.000225	CcSEcCtD
Sofosbuvir—Muscle spasms—Epirubicin—hematologic cancer	5.22e-05	0.000224	CcSEcCtD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—hematologic cancer	5.22e-05	0.00401	CbGpPWpGaD
Sofosbuvir—Mediastinal disorder—Doxorubicin—hematologic cancer	5.21e-05	0.000224	CcSEcCtD
Sofosbuvir—Chills—Doxorubicin—hematologic cancer	5.18e-05	0.000223	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.17e-05	0.000222	CcSEcCtD
Sofosbuvir—Dizziness—Prednisolone—hematologic cancer	5.16e-05	0.000222	CcSEcCtD
Sofosbuvir—Asthenia—Triamcinolone—hematologic cancer	5.15e-05	0.000221	CcSEcCtD
Sofosbuvir—Body temperature increased—Betamethasone—hematologic cancer	5.15e-05	0.000221	CcSEcCtD
Sofosbuvir—Body temperature increased—Dexamethasone—hematologic cancer	5.15e-05	0.000221	CcSEcCtD
Sofosbuvir—Nausea—Cisplatin—hematologic cancer	5.13e-05	0.00022	CcSEcCtD
Sofosbuvir—Insomnia—Prednisone—hematologic cancer	5.13e-05	0.00022	CcSEcCtD
Sofosbuvir—Vision blurred—Epirubicin—hematologic cancer	5.12e-05	0.00022	CcSEcCtD
Sofosbuvir—Alopecia—Doxorubicin—hematologic cancer	5.1e-05	0.000219	CcSEcCtD
Sofosbuvir—Pruritus—Triamcinolone—hematologic cancer	5.08e-05	0.000218	CcSEcCtD
Sofosbuvir—Cough—Methotrexate—hematologic cancer	5.07e-05	0.000218	CcSEcCtD
Sofosbuvir—Vomiting—Etoposide—hematologic cancer	5.03e-05	0.000216	CcSEcCtD
Sofosbuvir—Malnutrition—Doxorubicin—hematologic cancer	5.03e-05	0.000216	CcSEcCtD
Sofosbuvir—Anaemia—Epirubicin—hematologic cancer	5.02e-05	0.000216	CcSEcCtD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—hematologic cancer	5.02e-05	0.00386	CbGpPWpGaD
Sofosbuvir—Agitation—Epirubicin—hematologic cancer	4.99e-05	0.000215	CcSEcCtD
Sofosbuvir—Dyspepsia—Prednisone—hematologic cancer	4.99e-05	0.000214	CcSEcCtD
Sofosbuvir—Rash—Etoposide—hematologic cancer	4.99e-05	0.000214	CcSEcCtD
Sofosbuvir—Dermatitis—Etoposide—hematologic cancer	4.98e-05	0.000214	CcSEcCtD
Sofosbuvir—Headache—Etoposide—hematologic cancer	4.96e-05	0.000213	CcSEcCtD
Sofosbuvir—Chest pain—Methotrexate—hematologic cancer	4.94e-05	0.000212	CcSEcCtD
Sofosbuvir—Arthralgia—Methotrexate—hematologic cancer	4.94e-05	0.000212	CcSEcCtD
Sofosbuvir—Myalgia—Methotrexate—hematologic cancer	4.94e-05	0.000212	CcSEcCtD
Sofosbuvir—Decreased appetite—Prednisone—hematologic cancer	4.93e-05	0.000212	CcSEcCtD
Sofosbuvir—Rash—Prednisolone—hematologic cancer	4.92e-05	0.000211	CcSEcCtD
Sofosbuvir—Dermatitis—Prednisolone—hematologic cancer	4.92e-05	0.000211	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.91e-05	0.000211	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—CD86—hematologic cancer	4.89e-05	0.00376	CbGpPWpGaD
Sofosbuvir—Fatigue—Prednisone—hematologic cancer	4.89e-05	0.00021	CcSEcCtD
Sofosbuvir—Headache—Prednisolone—hematologic cancer	4.89e-05	0.00021	CcSEcCtD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—TERT—hematologic cancer	4.88e-05	0.00375	CbGpPWpGaD
Sofosbuvir—Back pain—Doxorubicin—hematologic cancer	4.86e-05	0.000209	CcSEcCtD
Sofosbuvir—Constipation—Prednisone—hematologic cancer	4.85e-05	0.000208	CcSEcCtD
Sofosbuvir—Muscle spasms—Doxorubicin—hematologic cancer	4.83e-05	0.000208	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—CD40LG—hematologic cancer	4.79e-05	0.00368	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—IL10—hematologic cancer	4.79e-05	0.00368	CbGpPWpGaD
Sofosbuvir—Dizziness—Triamcinolone—hematologic cancer	4.75e-05	0.000204	CcSEcCtD
Sofosbuvir—Cough—Epirubicin—hematologic cancer	4.74e-05	0.000204	CcSEcCtD
Sofosbuvir—Vision blurred—Doxorubicin—hematologic cancer	4.74e-05	0.000204	CcSEcCtD
Sofosbuvir—Infection—Methotrexate—hematologic cancer	4.71e-05	0.000202	CcSEcCtD
Sofosbuvir—Nausea—Etoposide—hematologic cancer	4.7e-05	0.000202	CcSEcCtD
Sofosbuvir—Asthenia—Dexamethasone—hematologic cancer	4.67e-05	0.000201	CcSEcCtD
Sofosbuvir—Asthenia—Betamethasone—hematologic cancer	4.67e-05	0.000201	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—IL4—hematologic cancer	4.66e-05	0.00358	CbGpPWpGaD
Sofosbuvir—Nervous system disorder—Methotrexate—hematologic cancer	4.65e-05	0.0002	CcSEcCtD
Sofosbuvir—Anaemia—Doxorubicin—hematologic cancer	4.65e-05	0.0002	CcSEcCtD
Sofosbuvir—Nausea—Prednisolone—hematologic cancer	4.64e-05	0.000199	CcSEcCtD
Sofosbuvir—Chest pain—Epirubicin—hematologic cancer	4.63e-05	0.000199	CcSEcCtD
Sofosbuvir—Arthralgia—Epirubicin—hematologic cancer	4.63e-05	0.000199	CcSEcCtD
Sofosbuvir—Myalgia—Epirubicin—hematologic cancer	4.63e-05	0.000199	CcSEcCtD
Sofosbuvir—Agitation—Doxorubicin—hematologic cancer	4.62e-05	0.000199	CcSEcCtD
Sofosbuvir—Anxiety—Epirubicin—hematologic cancer	4.61e-05	0.000198	CcSEcCtD
Sofosbuvir—Pruritus—Betamethasone—hematologic cancer	4.61e-05	0.000198	CcSEcCtD
Sofosbuvir—Pruritus—Dexamethasone—hematologic cancer	4.61e-05	0.000198	CcSEcCtD
Sofosbuvir—Skin disorder—Methotrexate—hematologic cancer	4.6e-05	0.000198	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.59e-05	0.000197	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—PDGFRA—hematologic cancer	4.59e-05	0.00353	CbGpPWpGaD
Sofosbuvir—Vomiting—Triamcinolone—hematologic cancer	4.56e-05	0.000196	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—HLA-B—hematologic cancer	4.56e-05	0.0035	CbGpPWpGaD
Sofosbuvir—Rash—Triamcinolone—hematologic cancer	4.52e-05	0.000194	CcSEcCtD
Sofosbuvir—Dry mouth—Epirubicin—hematologic cancer	4.52e-05	0.000194	CcSEcCtD
Sofosbuvir—Dermatitis—Triamcinolone—hematologic cancer	4.52e-05	0.000194	CcSEcCtD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—hematologic cancer	4.5e-05	0.00346	CbGpPWpGaD
Sofosbuvir—Headache—Triamcinolone—hematologic cancer	4.5e-05	0.000193	CcSEcCtD
Sofosbuvir—Body temperature increased—Prednisone—hematologic cancer	4.48e-05	0.000193	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—FASLG—hematologic cancer	4.46e-05	0.00342	CbGpPWpGaD
Sofosbuvir—Diarrhoea—Betamethasone—hematologic cancer	4.45e-05	0.000191	CcSEcCtD
Sofosbuvir—Diarrhoea—Dexamethasone—hematologic cancer	4.45e-05	0.000191	CcSEcCtD
Sofosbuvir—Infection—Epirubicin—hematologic cancer	4.41e-05	0.000189	CcSEcCtD
Sofosbuvir—Cough—Doxorubicin—hematologic cancer	4.39e-05	0.000189	CcSEcCtD
Sofosbuvir—Nervous system disorder—Epirubicin—hematologic cancer	4.35e-05	0.000187	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.32e-05	0.000186	CcSEcCtD
Sofosbuvir—Skin disorder—Epirubicin—hematologic cancer	4.31e-05	0.000185	CcSEcCtD
Sofosbuvir—Dizziness—Dexamethasone—hematologic cancer	4.31e-05	0.000185	CcSEcCtD
Sofosbuvir—Dizziness—Betamethasone—hematologic cancer	4.31e-05	0.000185	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—FAS—hematologic cancer	4.3e-05	0.0033	CbGpPWpGaD
Sofosbuvir—Insomnia—Methotrexate—hematologic cancer	4.29e-05	0.000184	CcSEcCtD
Sofosbuvir—Arthralgia—Doxorubicin—hematologic cancer	4.28e-05	0.000184	CcSEcCtD
Sofosbuvir—Myalgia—Doxorubicin—hematologic cancer	4.28e-05	0.000184	CcSEcCtD
Sofosbuvir—Chest pain—Doxorubicin—hematologic cancer	4.28e-05	0.000184	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—IL2RA—hematologic cancer	4.27e-05	0.00328	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—hematologic cancer	4.27e-05	0.00328	CbGpPWpGaD
Sofosbuvir—Anxiety—Doxorubicin—hematologic cancer	4.27e-05	0.000183	CcSEcCtD
Sofosbuvir—Nausea—Triamcinolone—hematologic cancer	4.26e-05	0.000183	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.25e-05	0.000183	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—HLA-A—hematologic cancer	4.23e-05	0.00325	CbGpPWpGaD
Sofosbuvir—Dyspnoea—Methotrexate—hematologic cancer	4.22e-05	0.000182	CcSEcCtD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—AQP9—hematologic cancer	4.19e-05	0.00322	CbGpPWpGaD
Sofosbuvir—Dry mouth—Doxorubicin—hematologic cancer	4.19e-05	0.00018	CcSEcCtD
Sofosbuvir—Dyspepsia—Methotrexate—hematologic cancer	4.17e-05	0.000179	CcSEcCtD
Sofosbuvir—Vomiting—Betamethasone—hematologic cancer	4.14e-05	0.000178	CcSEcCtD
Sofosbuvir—Vomiting—Dexamethasone—hematologic cancer	4.14e-05	0.000178	CcSEcCtD
Sofosbuvir—Decreased appetite—Methotrexate—hematologic cancer	4.12e-05	0.000177	CcSEcCtD
Sofosbuvir—Rash—Betamethasone—hematologic cancer	4.11e-05	0.000176	CcSEcCtD
Sofosbuvir—Rash—Dexamethasone—hematologic cancer	4.11e-05	0.000176	CcSEcCtD
Sofosbuvir—Dermatitis—Dexamethasone—hematologic cancer	4.1e-05	0.000176	CcSEcCtD
Sofosbuvir—Dermatitis—Betamethasone—hematologic cancer	4.1e-05	0.000176	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.09e-05	0.000176	CcSEcCtD
Sofosbuvir—Fatigue—Methotrexate—hematologic cancer	4.09e-05	0.000176	CcSEcCtD
Sofosbuvir—Headache—Betamethasone—hematologic cancer	4.08e-05	0.000175	CcSEcCtD
Sofosbuvir—Headache—Dexamethasone—hematologic cancer	4.08e-05	0.000175	CcSEcCtD
Sofosbuvir—Infection—Doxorubicin—hematologic cancer	4.08e-05	0.000175	CcSEcCtD
Sofosbuvir—Asthenia—Prednisone—hematologic cancer	4.07e-05	0.000175	CcSEcCtD
Sofosbuvir—Pain—Methotrexate—hematologic cancer	4.05e-05	0.000174	CcSEcCtD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	4.04e-05	0.00311	CbGpPWpGaD
Sofosbuvir—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.04e-05	0.000174	CcSEcCtD
Sofosbuvir—Nervous system disorder—Doxorubicin—hematologic cancer	4.02e-05	0.000173	CcSEcCtD
Sofosbuvir—Pruritus—Prednisone—hematologic cancer	4.01e-05	0.000172	CcSEcCtD
Sofosbuvir—Insomnia—Epirubicin—hematologic cancer	4.01e-05	0.000172	CcSEcCtD
Sofosbuvir—Skin disorder—Doxorubicin—hematologic cancer	3.99e-05	0.000171	CcSEcCtD
Sofosbuvir—Dyspnoea—Epirubicin—hematologic cancer	3.95e-05	0.00017	CcSEcCtD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—FOS—hematologic cancer	3.92e-05	0.00301	CbGpPWpGaD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—CREB1—hematologic cancer	3.91e-05	0.00301	CbGpPWpGaD
Sofosbuvir—Dyspepsia—Epirubicin—hematologic cancer	3.9e-05	0.000168	CcSEcCtD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	3.9e-05	0.00299	CbGpPWpGaD
Sofosbuvir—Diarrhoea—Prednisone—hematologic cancer	3.88e-05	0.000167	CcSEcCtD
Sofosbuvir—Nausea—Betamethasone—hematologic cancer	3.87e-05	0.000166	CcSEcCtD
Sofosbuvir—Nausea—Dexamethasone—hematologic cancer	3.87e-05	0.000166	CcSEcCtD
Sofosbuvir—Decreased appetite—Epirubicin—hematologic cancer	3.86e-05	0.000166	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.83e-05	0.000165	CcSEcCtD
Sofosbuvir—Fatigue—Epirubicin—hematologic cancer	3.82e-05	0.000164	CcSEcCtD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—CREBBP—hematologic cancer	3.81e-05	0.00293	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	3.81e-05	0.00292	CbGpPWpGaD
Sofosbuvir—Constipation—Epirubicin—hematologic cancer	3.79e-05	0.000163	CcSEcCtD
Sofosbuvir—Pain—Epirubicin—hematologic cancer	3.79e-05	0.000163	CcSEcCtD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—hematologic cancer	3.75e-05	0.00288	CbGpPWpGaD
Sofosbuvir—Dizziness—Prednisone—hematologic cancer	3.75e-05	0.000161	CcSEcCtD
Sofosbuvir—Body temperature increased—Methotrexate—hematologic cancer	3.75e-05	0.000161	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.74e-05	0.000161	CcSEcCtD
Sofosbuvir—Insomnia—Doxorubicin—hematologic cancer	3.71e-05	0.000159	CcSEcCtD
Sofosbuvir—Dyspnoea—Doxorubicin—hematologic cancer	3.66e-05	0.000157	CcSEcCtD
Sofosbuvir—Dyspepsia—Doxorubicin—hematologic cancer	3.61e-05	0.000155	CcSEcCtD
Sofosbuvir—Vomiting—Prednisone—hematologic cancer	3.61e-05	0.000155	CcSEcCtD
Sofosbuvir—Rash—Prednisone—hematologic cancer	3.58e-05	0.000154	CcSEcCtD
Sofosbuvir—Dermatitis—Prednisone—hematologic cancer	3.57e-05	0.000153	CcSEcCtD
Sofosbuvir—Decreased appetite—Doxorubicin—hematologic cancer	3.57e-05	0.000153	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—CD80—hematologic cancer	3.57e-05	0.00274	CbGpPWpGaD
Sofosbuvir—Headache—Prednisone—hematologic cancer	3.55e-05	0.000153	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.54e-05	0.000152	CcSEcCtD
Sofosbuvir—Fatigue—Doxorubicin—hematologic cancer	3.54e-05	0.000152	CcSEcCtD
Sofosbuvir—Constipation—Doxorubicin—hematologic cancer	3.51e-05	0.000151	CcSEcCtD
Sofosbuvir—Pain—Doxorubicin—hematologic cancer	3.51e-05	0.000151	CcSEcCtD
Sofosbuvir—Body temperature increased—Epirubicin—hematologic cancer	3.51e-05	0.000151	CcSEcCtD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—hematologic cancer	3.48e-05	0.00267	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	3.46e-05	0.00266	CbGpPWpGaD
Sofosbuvir—Asthenia—Methotrexate—hematologic cancer	3.4e-05	0.000146	CcSEcCtD
Sofosbuvir—Nausea—Prednisone—hematologic cancer	3.37e-05	0.000145	CcSEcCtD
Sofosbuvir—Pruritus—Methotrexate—hematologic cancer	3.35e-05	0.000144	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—CASP8—hematologic cancer	3.32e-05	0.00255	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	3.31e-05	0.00254	CbGpPWpGaD
Sofosbuvir—Body temperature increased—Doxorubicin—hematologic cancer	3.24e-05	0.000139	CcSEcCtD
Sofosbuvir—Diarrhoea—Methotrexate—hematologic cancer	3.24e-05	0.000139	CcSEcCtD
Sofosbuvir—Asthenia—Epirubicin—hematologic cancer	3.18e-05	0.000137	CcSEcCtD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—S100A10—hematologic cancer	3.18e-05	0.00244	CbGpPWpGaD
Sofosbuvir—Pruritus—Epirubicin—hematologic cancer	3.14e-05	0.000135	CcSEcCtD
Sofosbuvir—Dizziness—Methotrexate—hematologic cancer	3.13e-05	0.000135	CcSEcCtD
Sofosbuvir—Diarrhoea—Epirubicin—hematologic cancer	3.03e-05	0.00013	CcSEcCtD
Sofosbuvir—Vomiting—Methotrexate—hematologic cancer	3.01e-05	0.000129	CcSEcCtD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	3.01e-05	0.00231	CbGpPWpGaD
Sofosbuvir—Rash—Methotrexate—hematologic cancer	2.99e-05	0.000128	CcSEcCtD
Sofosbuvir—Dermatitis—Methotrexate—hematologic cancer	2.99e-05	0.000128	CcSEcCtD
Sofosbuvir—Headache—Methotrexate—hematologic cancer	2.97e-05	0.000128	CcSEcCtD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	2.95e-05	0.00227	CbGpPWpGaD
Sofosbuvir—Asthenia—Doxorubicin—hematologic cancer	2.94e-05	0.000127	CcSEcCtD
Sofosbuvir—Dizziness—Epirubicin—hematologic cancer	2.93e-05	0.000126	CcSEcCtD
Sofosbuvir—Pruritus—Doxorubicin—hematologic cancer	2.9e-05	0.000125	CcSEcCtD
Sofosbuvir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	2.87e-05	0.00221	CbGpPWpGaD
Sofosbuvir—Vomiting—Epirubicin—hematologic cancer	2.82e-05	0.000121	CcSEcCtD
Sofosbuvir—ABCB1—Allograft Rejection—IFNG—hematologic cancer	2.82e-05	0.00217	CbGpPWpGaD
Sofosbuvir—Nausea—Methotrexate—hematologic cancer	2.81e-05	0.000121	CcSEcCtD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—JUN—hematologic cancer	2.81e-05	0.00216	CbGpPWpGaD
Sofosbuvir—Diarrhoea—Doxorubicin—hematologic cancer	2.81e-05	0.000121	CcSEcCtD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	2.8e-05	0.00215	CbGpPWpGaD
Sofosbuvir—Rash—Epirubicin—hematologic cancer	2.8e-05	0.00012	CcSEcCtD
Sofosbuvir—Dermatitis—Epirubicin—hematologic cancer	2.79e-05	0.00012	CcSEcCtD
Sofosbuvir—Headache—Epirubicin—hematologic cancer	2.78e-05	0.000119	CcSEcCtD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.78e-05	0.00213	CbGpPWpGaD
Sofosbuvir—Dizziness—Doxorubicin—hematologic cancer	2.71e-05	0.000117	CcSEcCtD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	2.71e-05	0.00208	CbGpPWpGaD
Sofosbuvir—Nausea—Epirubicin—hematologic cancer	2.63e-05	0.000113	CcSEcCtD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.63e-05	0.00202	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	2.62e-05	0.00201	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	2.61e-05	0.00201	CbGpPWpGaD
Sofosbuvir—Vomiting—Doxorubicin—hematologic cancer	2.61e-05	0.000112	CcSEcCtD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—EP300—hematologic cancer	2.6e-05	0.00199	CbGpPWpGaD
Sofosbuvir—Rash—Doxorubicin—hematologic cancer	2.59e-05	0.000111	CcSEcCtD
Sofosbuvir—Dermatitis—Doxorubicin—hematologic cancer	2.58e-05	0.000111	CcSEcCtD
Sofosbuvir—Headache—Doxorubicin—hematologic cancer	2.57e-05	0.00011	CcSEcCtD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	2.52e-05	0.00193	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	2.52e-05	0.00193	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—IL1B—hematologic cancer	2.51e-05	0.00193	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—CASP3—hematologic cancer	2.51e-05	0.00193	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—IL2—hematologic cancer	2.51e-05	0.00192	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	2.49e-05	0.00192	CbGpPWpGaD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	2.46e-05	0.00189	CbGpPWpGaD
Sofosbuvir—Nausea—Doxorubicin—hematologic cancer	2.44e-05	0.000105	CcSEcCtD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.41e-05	0.00185	CbGpPWpGaD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.41e-05	0.00185	CbGpPWpGaD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.41e-05	0.00185	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	2.34e-05	0.0018	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	2.31e-05	0.00177	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	2.27e-05	0.00174	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	2.2e-05	0.00169	CbGpPWpGaD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.17e-05	0.00166	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—FTCD—hematologic cancer	2.15e-05	0.00165	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—GMPS—hematologic cancer	2.15e-05	0.00165	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—PHYH—hematologic cancer	2.15e-05	0.00165	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	2.13e-05	0.00164	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	2.12e-05	0.00163	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	1.97e-05	0.00152	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—SMPD3—hematologic cancer	1.96e-05	0.00151	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	1.95e-05	0.0015	CbGpPWpGaD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.9e-05	0.00146	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	1.89e-05	0.00146	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	1.87e-05	0.00144	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	1.87e-05	0.00143	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	1.86e-05	0.00143	CbGpPWpGaD
Sofosbuvir—ABCB1—Allograft Rejection—TNF—hematologic cancer	1.82e-05	0.0014	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	1.81e-05	0.00139	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	1.81e-05	0.00139	CbGpPWpGaD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.74e-05	0.00134	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—ASNS—hematologic cancer	1.72e-05	0.00132	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—DCK—hematologic cancer	1.72e-05	0.00132	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—B3GAT1—hematologic cancer	1.72e-05	0.00132	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	1.67e-05	0.00128	CbGpPWpGaD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.64e-05	0.00126	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	1.64e-05	0.00126	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	1.63e-05	0.00125	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—HDC—hematologic cancer	1.63e-05	0.00125	CbGpPWpGaD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.59e-05	0.00122	CbGpPWpGaD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.58e-05	0.00122	CbGpPWpGaD
Sofosbuvir—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	1.57e-05	0.00121	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.55e-05	0.00119	CbGpPWpGaD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.55e-05	0.00119	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—CDA—hematologic cancer	1.49e-05	0.00114	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.48e-05	0.00114	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—PC—hematologic cancer	1.43e-05	0.0011	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.4e-05	0.00108	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.38e-05	0.00106	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.38e-05	0.00106	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—GBA—hematologic cancer	1.38e-05	0.00106	CbGpPWpGaD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.38e-05	0.00106	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—MTAP—hematologic cancer	1.26e-05	0.000972	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.26e-05	0.000971	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.24e-05	0.000951	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.21e-05	0.000926	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.2e-05	0.000924	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.17e-05	0.000896	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.16e-05	0.000894	CbGpPWpGaD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.16e-05	0.000891	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.14e-05	0.000874	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—FHL2—hematologic cancer	1.13e-05	0.000866	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.11e-05	0.000852	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—AGRN—hematologic cancer	1.11e-05	0.000849	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.08e-05	0.000829	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.05e-05	0.000807	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—HMMR—hematologic cancer	1.05e-05	0.000805	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—IDH2—hematologic cancer	1.05e-05	0.000805	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	9.94e-06	0.000764	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—ARNTL—hematologic cancer	9.85e-06	0.000757	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	9.67e-06	0.000743	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	9.64e-06	0.000741	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—CA9—hematologic cancer	9.58e-06	0.000736	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—ACP5—hematologic cancer	9.58e-06	0.000736	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—NCOR2—hematologic cancer	9.46e-06	0.000727	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—IDH1—hematologic cancer	9.01e-06	0.000692	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	9.01e-06	0.000692	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	8.93e-06	0.000686	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—GSTO1—hematologic cancer	8.91e-06	0.000685	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—ABCC3—hematologic cancer	8.91e-06	0.000685	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—TXN—hematologic cancer	8.91e-06	0.000685	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—SPHK1—hematologic cancer	8.72e-06	0.00067	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—UGT1A1—hematologic cancer	8.38e-06	0.000644	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	8.21e-06	0.000631	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—CRABP1—hematologic cancer	8.15e-06	0.000626	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—SLC22A1—hematologic cancer	8.15e-06	0.000626	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—ALOX5—hematologic cancer	7.94e-06	0.00061	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	7.94e-06	0.00061	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—NUP98—hematologic cancer	7.69e-06	0.000591	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—ADCY7—hematologic cancer	7.47e-06	0.000574	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—NCOA3—hematologic cancer	7.47e-06	0.000574	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—NUP214—hematologic cancer	7.41e-06	0.00057	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—MTR—hematologic cancer	7.26e-06	0.000558	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—ABCG2—hematologic cancer	7.26e-06	0.000558	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—ENO2—hematologic cancer	7.12e-06	0.000547	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—GSTT1—hematologic cancer	6.91e-06	0.000531	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—SDC1—hematologic cancer	6.75e-06	0.000519	CbGpPWpGaD
Sofosbuvir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.7e-06	0.000515	CbGpPWpGaD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.47e-06	0.000497	CbGpPWpGaD
Sofosbuvir—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	6.05e-06	0.000465	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—NQO1—hematologic cancer	5.74e-06	0.000441	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—CD44—hematologic cancer	5.74e-06	0.000441	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—CYCS—hematologic cancer	5.43e-06	0.000417	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—HSP90AA1—hematologic cancer	5.4e-06	0.000415	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—GSTP1—hematologic cancer	4.79e-06	0.000368	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—GSTM1—hematologic cancer	4.4e-06	0.000338	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—NCOR1—hematologic cancer	4.4e-06	0.000338	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—MTHFR—hematologic cancer	3.89e-06	0.000299	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.27e-06	0.000251	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—CREBBP—hematologic cancer	3.03e-06	0.000233	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.87e-06	0.000221	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—ALB—hematologic cancer	2.84e-06	0.000218	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.71e-06	0.000208	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.5e-06	0.000192	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—PTEN—hematologic cancer	2.16e-06	0.000166	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—EP300—hematologic cancer	2.06e-06	0.000159	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.53e-06	0.000117	CbGpPWpGaD
Sofosbuvir—ABCB1—Metabolism—AKT1—hematologic cancer	1.25e-06	9.58e-05	CbGpPWpGaD
